Effect of hyperoside on the apoptosis of A549 human non-small cell lung cancer cells and the underlying mechanism

Abstract

Hyperoside (HY) is a major pharmacologically active component from Prunella vulgaris L. and Hypericum perforatum. The present study aimed to determine the anticancer effect of HY and determine the underlying mechanisms involved. Human A549 cells were treated with HY (10, 50 and 100 µM), and cell viability was detected by an MTT assay. Cell apoptosis and mitochondrial membrane potential were determined by flow cytometry. Western blot analysis was used to identify the expression of apoptosis-associated proteins and phosphorylation of MAPK. The present study demonstrated that HY significantly inhibited the viability of A549 cells in a time- and dose-dependent manner, and enhanced the percentage of apoptotic cells. HY also significantly increased the protein phosphorylation of p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK), disrupted mitochondrial membrane penetrability, and triggered the release of mitochondrial cytochrome c and apoptosis-inducing factor into the cytosol. Treatment with HY also activated the expression of caspase-9 and caspase-3. These results suggested that HY-induced apoptosis was associated with activation of the p38 MAPK- and JNK-induced mitochondrial death pathway. HY may offer potential for clinical applications in treating human non-small cell lung cancer and improving cancer chemotherapy.

Introduction

Lung cancer, characterized by high incidence and mortality rates, is a malignant tumor, which threatens human health. It is reported that the incidence and mortality rates have increased significantly in several countries in the last 50 years (1,2). The etiology of lung cancer remains to be fully elucidated, and there is substantial data showing a close association between long-term heavy smoking and the occurrence of lung cancer (2). Non-small cell lung cancer (NSCLC) accounts for ~80% of all lung cancer cases, and ~75% of patients are diagnosed in the middle-late stage (3,4). Therapies for NSCLC include surgery, radiation and chemotherapy; however, the 5-year survival rate remains low. In addition, the side effects and pain from treatment cause substantial physical and mental trauma to patients. In previous years, the screening of compounds from medicinal plants for the treatment of various diseases has received increased attention. For example, the anticancer drug, paclitaxel (Taxol), obtained from Taxus species has been extensively investigated for several years (5). Therefore, obtaining anticancer compounds from medicinal plants is important in cancer treatment.

Hyperoside (HY; Fig. 1) is a major pharmacologically active component from Prunella vulgaris L. and Hypericum perforatum, which exerts a wide variety of biological activities, including antioxidant, antihyperglycemic, anticancer, anti-inflammatory and cardiovascular protective effects (6–9). However, the underlying molecular mechanisms remain to be fully elucidated. The present study aimed to determine the anticancer effect of HY and identifying the possible mechanism involved. In the present study, HY was identified as an anticancer agent, which induced the apoptosis of human NSCLC A549 cells though the mitochondria apoptotic pathway.

Figure 1.

Chemical structure of hyperoside.

Materials and methods

Cell culture

A549 cells were obtained from the Shanghai Cell Bank, Chinese Academy of Sciences (Shanghai, China). The cells were cultured in DMEM (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS; Invitrogen; Thermo Fisher Scientific, Inc.), 100 U/ml penicillin and 100 µg/ml streptomycin, and incubated in a humidified atmosphere at 37°C with 5% CO₂.

HY preparation

HY with a purity of 98.78% was obtained as a canary yellow needle-shaped crystal (YUANYE Technological Co. Ltd., Shanghai, China). It was dissolved in an appropriate volume of dimethylsulfoxide (DMSO) and diluted to the desired concentrations (10, 50 and 100 µM) prior to utilization, with the final concentration of DMSO maintained below 0.5%.

Cell viability

A standard tetrazolium bromide (MTT) assay was used to assess cell viability. Briefly, the cells (5×10³ cells/well) were seeded in 96-well plates. Following treatment with HY (0, 10, 50 and 100 µM) for 24 h at 37°C, 50 ml of MTT (Sigma-Aldrich; Merck Millipore, Darmstadt, Germany) solution (2 mg/ml in PBS) was added to each well and the plates were incubated for an additional 4 h at 37°C. The medium was then removed and the cells were incubated with 200 µl DMSO in the dark for 30 min at 37°C to dissolve violet crystals. The absorbance was read at 570 nm on an automatic microplate reader with DMSO as the blank control. All assays were performed with five replicates and repeated at least three times.

Cell apoptosis

In order to determine cell apoptosis, 5×10⁴ cells were trypsinized, washed with cold phosphate-buffered saline (PBS) and resuspended in binding buffer according to the manufacturer's protocol of the Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) Apoptosis Detection kit (cat. no. KGA106; Nanjing KeyGen Biotech Co., Ltd., Nanjing, China). FITC-Annexin V and PI were added to the fixed cells for 20 min in darkness at room temperature. Subsequently, Annexin V binding buffer was added to the mixture prior to quantifying the fluorescence using a FACSort flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). Cell apoptosis was analyzed using Cell Quest version 3.0 (BD Biosciences).

Mitochondrial membrane potential (MMP)

Rhodamine-123 (Rho-123) dye (Sigma-Aldrich; Merck Millipore) was used to detect alterations in MMP. The cells (5×10⁴ cells/well) were cultured in a 24-well plate. Following treatment with HY (0, 10, 50 and 100 µM) for 24 h, the cells were washed with PBS, incubated with Rho-123 (10 mg/ml) for 30 min at 37°C and subsequently subjected to flow cytometry.

Separation of mitochondrial and cytosolic fractions

A mitochondria/cytosol fractionation kit (Abcam, Cambridge, UK) was used to prepare the mitochondrial and cytosolic fractions from the cells, in accordance with the manufacturer's protocol. Following treatment for 12 h with the different concentrations of HY, the cells were harvested, washed by PBS and centrifuged at 600 × g for 5 min at 4°C. Following re-suspension with cytosolic extraction buffer, the cells were homogenized on ice for 40 passes with a grinder for 10 min. The homogenate was subsequently centrifuged at 700 × g for 10 min at 4°C, supernatant was carefully collected, and the sediment was saved. Following centrifugation at 10,000 × g for 30 min at 4°C, the supernatant was collected as the cytosolic fraction and stored at −80°C. The sediment was re-suspended with mitochondrial extraction buffer, vortexed and stored as the mitochondrial fraction at −80°C.

Western blot analysis

The cultured cells were harvested and washed twice with PBS, and lysed in ice-cold radioimmunoprecipitation assay buffer (Beyotime Institute of Biotechnology, Shanghai, China) with freshly added 0.01% protease inhibitor cocktail (Sigma-Aldrich; Merck Millipore) and incubated on ice for 30 min. The cell lysate was centrifuged at 13,000 × g for 10 min at 4°C, following which the supernatant was run on a 10% SDS-PAGE gel and transferred electrophoretically onto a polyvinylidene fluoride membrane (EMD Millipore, Billerica, MA, USA). The blots were blocked with 5% skim milk, followed by incubation with antibodies against phosphorylated (P)-c-Jun N-terminal kinase (P-JNK; cat. no. ab4821; 1:500; Abcam), JNK (cat. no. ab154902; 1:200; Abcam), P-P38 (cat. no. ab47363; 1:500; Abcam), P38 (cat. no. ab170099; 1:1,000; Abcam), GAPDH (cat. no. ab9485; 1:2,500; Abcam), apoptosis-inducing factor (AIF; cat. no. ab1998; 1:500; Abcam), cytochrome c (cat. no. ab13575; 1:500; Abcam), caspase-3 (cat. no. ab2171; 1:500; Abcam) and caspase-9 (cat. no. ab32539, 1:1,000; Abcam) at 4°C overnight. The blots were then incubated with goat anti-mouse or anti-rabbit secondary antibody (Beyotime Institute of Biotechnology, Shanghai, China) at room temperature for 1 h and visualized using SuperSignal West Dura Extended Duration substrate (Thermo Fisher Scientific, Inc.) and detected using a DNR Bio-Imaging System (DNR Bio-Imaging Systems, Ltd., Jerusalem, Israel). Protein density levels were determined by Image Analysis software version 4.0.3.2 (Scion Co., Ltd., Frederick, MD, USA) and the densitometric analysis of blots from three experiments.

Statistical analysis

All results are presented as the mean ± standard deviation and the data were analyzed using the SPSS 13.0 statistical package (SPSS, Inc., Chicago, IL, USA). Data for multiple comparisons were subjected to one-way analysis of variance followed by Dunnett's test. P<0.05 was considered to indicate a statistically significant difference.

Results

HY suppresses the viability of A549 cells

Following treatment of the cells with various concentrations of HY (0, 10, 50 and 100 µM) for 12, 24 and 48 h, cell viability was determined using an MTT assay. As shown in Fig. 2, HY inhibited the viability of the A549 cells in a time- and dose-dependent manner. Cell proliferation was markedly decreased, compared with that in the control group.

Figure 2.

HY inhibits the proliferation of A549 cells. Following treatment with HY (10, 50 and 100 µM) for 12, 24 and 48 h, cell viability was detected using tetrazolium bromide. Data are presented as the mean ± standard deviation (n=6). **P<0.01, compared with the control group. HY, hyperoside; OD, optical density.

HY induces the apoptosis of cells

In order to quantify cellular apoptosis, a flow cytometric assay was performed to analyze the proportion of apoptotic cells dyed with PI and Annexin V, to enable evaluation of the integrity of cell membrane and the externalization of phosphatidylserine. As shown in Fig. 3, analysis of the cell population revealed distinct sets within the population. The majority of cells were alive in the control group (Fig. 3). However, when the cells were incubated with various concentrations of HY for 24 h, there was a notable increase in the percentage of apoptotic cells, and this occurred in a dose-dependent manner.

Figure 3.

HY induces apoptosis of human A549 cells. The A549 cells were treated with HY (0, 10, 50 and 100 µM) for 24 h and cell apoptosis was assessed using flow cytometry. Data are presented as the mean ± standard deviation (n=6). **P<0.01, compared with the control group. HY, hyperoside. The lower left quadrant shows viable cells, which are negative for both AV and PI. The lower right quadrant displays early apoptotic cells, which are positive for AV and negative for PI. The upper right quadrant represents late apoptotic cells, which are positive for both AV and PI. The upper left quadrant indicates the cells damaged during the procedure. AV, Annexin V; PI propidium iodide.

HY enhances MMP dissipation

The fluorescent intensity (FI) of Rho123 is positively correlated with the MMP. As shown in Fig. 4, high intensity fluorescence was visible in the control group of cells. Following HY treatment for 24 h, FI decreased in a dose-dependent manner.

Figure 4.

HY enhances MMP dissipation. MMP was identified by the fluorescent intensity of rhodamine 123 following treatment with HY (0, 10, 50 and 100 µM) treatment for 24 h. Data was presented as the mean ± standard deviation (n=6). **P<0.01, compared with the control group. HY, hyperoside; MMP, mitochondrial membrane potential.

HY induces the release of cytochrome c and AIF

Following MMP dissipation, the key event of mitochondria-dependent apoptosis is the release of mitochondrial cytochrome c and AIF into cytosol. Therefore, these two parameters were evaluated using western blot analysis. The results revealed that the expression levels of cytochrome c and AIF (Fig. 5A) were lower in the control group of cells, and were significantly elevated by HY treatment for 24 h.

Figure 5.

Effects of HY on the protein expression of Cyt c, AIF, caspase-3 and caspase-9. (A) A549 cells treated with HY (0, 10, 50 and 100 µM) for 12 h. The cytosolic fractions of cells were prepared and the protein expression of levels of Cyt c and AIF were analyzed using western blot analysis, with GAPDH used as a loading control. (B) Expression levels of caspase-3 and caspase-9 were detected using western blot analysis. Data are presented as the mean ± standard deviation (n=3). **P<0.01, compared with the control group. HY, hyperoside; Cyt c, cytochrome c; AIF, apoptisis-inducing factor.

HY activates caspase-3 and caspase-9

Caspase-3, a common downstream apoptosis effector, can be activated by caspase-9 or caspase-8 and cleaved into the active fragment. In the present study, the protein expression levels of caspase-3 and caspase-9 were detected using western blot analysis. The expression levels of caspase-3 and caspase-9 in the control group were low (Fig. 5B). However, treatment with HY for 12 h elevated their expression levels in a dose-dependent manner.

HY facilitates protein phosphorylation of p38 mitogen-activated protein kinase (MAPK) and JNK

Cell apoptosis is closely associated with activation of the JNK and p38 MAPK signaling pathways, which is characterized by increased protein phosphorylation of p38 MAPK and/or JNK. Following treatment with HY for 3 h, the protein phosphorylation levels of p38 MAPK and JNK were analyzed using western blot analysis (Fig. 6A and B). Treatment with HY for 3 h increased the protein phosphorylation of p38 MAPK and JNK, and there were significant differences between the HY-treated groups and the control group.

Figure 6.

HY inhibits JNK and p38 signaling. A549 cells were treated with HY (10, 50, and 100 µM) for 3 h. Protein levels of (A) P-JNK, JNK, (B) P-p38 and p38 were identified using western blot analysis. GAPDH was used as a loading control. Data are presented as the mean ± standard deviation (n=3). *P<0.05, **P<0.01, compared with the control group. HY, hyperoside; JNK, and c-Jun N-terminal kinase; P-, phosphorylated.

Discussion

Higher plants produce an abundance of substances, which have been a reliable source of pharmaceuticals. In the present study, it was found that HY effectively inhibited the proliferation of human NSCLC A549 cells in a dose- and time-dependent manner. Furthermore, Annexin V/PI staining revealed that treatment with HY (10, 50 and 100 µM) for 12 h increased the percentage of apoptotic cells in a dose-dependent manner. These results indicated that HY induced apoptosis of the A549 cells.

MAPK pathways are generally recognized as the signal transducers of apoptosis in tumor cells, closely associated with responses to extracellular stimuli, including small molecular compounds (10–13). It is known that the MAPK system is composed of extracellular signal-regulated kinases, JNK and p38 MAP kinase. The JNK and p38 MAPK pathways can be activated by genotoxic agents and by the cytokine-mediating stress response, inducing growth inhibition and apoptosis in the cells (14). The induction of A549 cell apoptosis by 2-methoxy-1,4-naphthoquinone (MNQ) is independent of cell cycle arrest, and is mediated by the JNK and p38 MAPK signaling pathways. These signaling pathways have been found to be stimulated by oxidative DNA damage caused by the increased generation of reactive oxygen species (ROS) in the MNQ-treated A549 cells (14). It has been reported that capsaicin induces SMMC-7721 cell apoptosis through the generation of intracellular ROS, dissipation of MMP, and activation of the JNK and p38 MAPK pathways (15). Based on the above evidence, it is clear that p38 MAPK and JNK pathways are crucial in tumor cell apoptosis. In the present study, western blot analysis was used to identify the phosphorylation of p38 MAPK and JNK. The results revealed that HY significantly increased the phosphorylation levels of p38 MAPK and JNK, indicating the simultaneous activation of these two signaling pathways.

Activation of the intrinsic mitochondrial pathway can elicit the release of several apoptotic factors, including cytochrome c and AIF, which results in mitochondrial apoptosis and activates the mitochondrial apoptotic pathway. The release of cytochrome c facilitates the formation of the apoptosome-containing adaptor, apoptotic protease-activating factor-1, and another initiator, caspase-9, in the presence of dATP, following which caspase-3 is activated leading to cell apoptosis (16,17). AIF can elicit cell apoptosis independently of the activation of caspase-3 (18). The enhanced protein expression of activated caspase-3, a downstream effector caspase, indicated that HY triggered caspase-dependent apoptosis, which can be activated by the mitochondrial apoptotic pathway and/or the death receptor pathway. The present study also found that HY facilitated the loss of MMP, and the release of cytochrome c and AIF into the cytosol, and enhanced the protein expression of caspase-9. This indicated that HY induced apoptosis of the A549 cells via the mitochondrial apoptotic pathway.

In conclusion, the present study demonstrated that HY elevated the protein phosphorylation levels of p38 MAPK and JNK, disrupted MMP, facilitated the release of cytochrome c and AIF into cytoplasm, activated capase-9 and caspase-3, and led to apoptosis of the A549 cells. As a result, HY may offer potential as a useful and beneficial natural agent against lung cancer.